Literature DB >> 16162276

Tyrosine kinase activity and remodelling of the actin cytoskeleton are co-temporally required for degranulation by cytotoxic T lymphocytes.

Aimee Shen1, Lawrence G Puente, Hanne L Ostergaard.   

Abstract

In this study, we examined the contribution of the actin cytoskeleton to T-cell receptor (TCR)-initiated signalling in cytotoxic T lymphocytes (CTLs). We demonstrate that cytoskeletal remodelling is required for sustaining TCR-stimulated signals that lead to degranulation by CTLs. Disruption of the actin cytoskeleton in CTLs already undergoing signalling responses results in an almost immediate loss of essentially all protein tyrosine phosphorylation. This signal reversal is not restricted to tyrosine phosphorylation, as disruption of the actin cytoskeleton also reverses the phosphorylation of the more downstream serine/threonine kinase extracellular signal regulated kinase (Erk). An intact cytoskeleton and cell spreading are not sufficient for maintaining signals, as stabilization of actin filaments, at a point when peak tyrosine phosphorylation is occurring, also leads to the rapid loss of protein tyrosine phosphorylation. Disruption of tyrosine kinase activity after TCR signals are maximally induced causes the immediate reversal of tyrosine phosphorylation as well as cytoskeletal disruption, as indicated by loss of cell spreading, adhesion and CTL degranulation. Taken together, our results indicate that actin remodelling occurs co-temporally with ongoing tyrosine kinase activity, leading to CTL degranulation. We hypothesize that continuous actin remodelling is important for sustaining productive signals, even after downstream signalling molecules such as Erk have been activated, and that the actin cytoskeleton is not solely required for initiating and maintaining the T cell in contact with its stimulus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162276      PMCID: PMC1817816          DOI: 10.1111/j.1365-2567.2005.02222.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Inhibition of c-Abl tyrosine kinase activity by filamentous actin.

Authors:  P J Woodring; T Hunter; J Y Wang
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

2.  Requirement for Q226, but not multiple charged residues, in the class I MHC CD loop/D strand for TCR-activated CD8 accessory function.

Authors:  Micheal Durairaj; Ranjana Sharma; Jay C Varghese; Kevin P Kane
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

3.  The actin cytoskeleton and cytotoxic T lymphocytes: evidence for multiple roles that could affect granule exocytosis-dependent target cell killing.

Authors:  Taras A Lyubchenko; Georjeana A Wurth; Adam Zweifach
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

4.  Signal transduction through the T cell receptor is dynamically regulated by balancing kinase and phosphatase activities.

Authors:  Andrew E Schade; Alan D Levine
Journal:  Biochem Biophys Res Commun       Date:  2002-08-23       Impact factor: 3.575

5.  Sustained TCR signaling is required for mitogen-activated protein kinase activation and degranulation by cytotoxic T lymphocytes.

Authors:  N N Berg; L G Puente; W Dawicki; H L Ostergaard
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

Review 6.  The Wiskott-Aldrich syndrome protein: forging the link between actin and cell activation.

Authors:  Karen Badour; Jinyi Zhang; Katherine A Siminovitch
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

7.  Beta 1/beta 3 integrin ligation is uncoupled from ERK1/ERK2 activation in cytotoxic T lymphocytes.

Authors:  Lawrence G Puente; Hanne L Ostergaard
Journal:  J Leukoc Biol       Date:  2003-03       Impact factor: 4.962

8.  Dynamic actin polymerization drives T cell receptor-induced spreading: a role for the signal transduction adaptor LAT.

Authors:  S C Bunnell; V Kapoor; R P Trible; W Zhang; L E Samelson
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

9.  The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface.

Authors:  C Wülfing; A Bauch; G R Crabtree; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 10.  All roads lead to actin: the intimate relationship between TCR signaling and the cytoskeleton.

Authors:  Claudette L Fuller; Vivian L Braciale; Lawrence E Samelson
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

View more
  5 in total

1.  Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1.

Authors:  Risaku Fukumoto; Miroslav Dundr; Christophe Nicot; Anthony Adams; Valerio W Valeri; Lawrence E Samelson; Genoveffa Franchini
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

2.  Cofilin Mediates LPS-Induced Microglial Cell Activation and Associated Neurotoxicity Through Activation of NF-κB and JAK-STAT Pathway.

Authors:  Qasim Alhadidi; Zahoor A Shah
Journal:  Mol Neurobiol       Date:  2017-02-13       Impact factor: 5.590

3.  Bridging HIV-1 cellular latency and clinical long-term non-progressor: an interactomic view.

Authors:  Jin Yang; Zongxing Yang; Hangjun Lv; Yi Lou; Juan Wang; Nanping Wu
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

4.  Non-catalytic functions of Pyk2 and Fyn regulate late stage adhesion in human T cells.

Authors:  Nicole M Chapman; Ashley N Yoder; Jon C D Houtman
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

5.  AHR Signaling Dampens Inflammatory Signature in Neonatal Skin γδ T Cells.

Authors:  Katja Merches; Alfonso Schiavi; Heike Weighardt; Swantje Steinwachs; Nadine Teichweyde; Irmgard Förster; Katrin Hochrath; Beatrix Schumak; Natascia Ventura; Patrick Petzsch; Karl Köhrer; Charlotte Esser
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.